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FGF8Fibroblast growth factor (FGF) signalling has important roles in the development of the embryonic
pharyngeal (branchial) arches, but its effects on innervation of the arches and associated structures have not
been studied extensively. We investigated the consequences of deleting two receptor tyrosine kinase (RTK)
antagonists of the Sprouty (Spry) gene family on the early development of the branchial nerves. The
morphology of the facial, glossopharyngeal and vagus nerves are abnormal in Spry1−/−;Spry2−/− embryos.
We identify speciﬁc defects in the epibranchial placodes and neural crest, which contribute sensory neurons
and glia to these nerves. A dissection of the tissue-speciﬁc roles of these genes in branchial nerve development
shows that Sprouty gene deletion in the pharyngeal epithelia can affect both placode formation and neural
crest fate. However, epithelial-speciﬁc gene deletion only results in defects in the facial nerve and not the
glossopharyngeal and vagus nerves, suggesting that the facial nerve is most sensitive to perturbations in RTK
signalling. Reducing the Fgf8 gene dosage only partially rescued defects in the glossopharyngeal nerve and
was not sufﬁcient to rescue facial nerve defects, suggesting that FGF8 is functionally redundant with other RTK
ligands during facial nerve development.l Development, King's College
Kingdom. Fax: +44 20 7188
).
ational Heart & Lung Institute,
gdom.
 license. © 2011 Elsevier Inc. Open access under CC BY license. Introduction
The sensory innervation of the pharynx is provided by the
epibranchial ganglia: the geniculate, petrosal and nodose. These
neurons convey viscerosensory and gustatory information from the
pharynx to the brainstem. The geniculate is the distal ganglion of the
VIIth cranial nerve, the petrosal the distal ganglion of the IXth and the
nodose the distal Xth. Importantly, the neurons are not neural crest
derived but arise fromdiscrete thickenings of the cranial ectoderm, the
neurogenic placodes. The placodes that form these neurons are the
epibranchial placodes and these structures develop in close apposition
to the pharyngeal arches. The geniculate forms at the anterodorsal
margin of the second arch, the petrosal at the third arch and thenodose
placodes form alongside arches 4 and 6. Somatosensory innervation
for the pharynx arises from the neural crest-derived proximal ganglia
of these nerves (Baker and Bronner-Fraser, 2001; D'Amico-Martel and
Noden, 1983; Ladher et al., 2010; Schlosser, 2010).
The formation of the epibranchial placodes is a multi-step process.
Recent studies have demonstrated that the epibranchial and oticplacodes are derived from a pre-otic ﬁeld (or otic-epibranchial
progenitor domain (OEPD)) and that this region is induced by FGF
signals from the mesoderm and hindbrain. Several FGF ligands appear
to function in a redundant fashion at this step of development in
several species (Freter et al., 2008; Ladher et al., 2010; Sun et al., 2007;
Urness et al., 2010). Experiments in zebraﬁsh suggest that FGF
signalling is required for the subsequent speciﬁcation of the
epibranchial placodes and for the development of the pharyngeal
endoderm, which in turn provides appropriate signals that control
neurogenesis in the placodes (Nechiporuk et al., 2005, 2007). Studies
in the chick and zebraﬁsh have suggested that secreted signals such as
BMP7 from the endoderm regulate neurogenesis in the adjacent
epibranchial placodes (Begbie et al., 1999; Kriebitz et al., 2009).
Despite the abnormal segmentation of the pharyngeal apparatus
observed in mouse embryos with reduced Fgf8 expression (Frank
et al., 2002), the branchial sensory ganglia are reported to be normal
at E10.5 of development (Chi et al., 2003). In addition to the potential
roles of FGF ligands in early branchial nerve development, other
growth factors, such as Glial cell line-derived neurotrophic factor
(GDNF) are expressed during epibranchial placode development
(Homma et al., 2000; Kyuno and Jones, 2007; Suvanto et al., 1996).
Sprouty genes encode feedback antagonists of RTK signalling and
embryonic defects in Sprouty-deﬁcient embryos have been linked to
increased FGF and RET signalling (Mason et al., 2006). A recent study
has shown that the speciﬁcation of the otic placode from the OEPD is
limited by Spry1 and Spry2: in Spry1−/−;Spry2−/− embryos, the otic
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which presumably includes the precursors of the epibranchial
placodes (Mahoney Rogers et al., 2011). However, the role of Sprouty
genes in regulating the development of the epibranchial placodes has
not been addressed. In order to investigate the effects of deregulated
RTK signalling on the development of the branchial nerves in the
mouse embryo, we simultaneously deleted two Sprouty genes during
development. We provide evidence that Sprouty genes regulate RTK
signalling during formation of the epibranchial placodes, neurogen-
esis within the placodes and neural crest fate speciﬁcation. However,
our data also suggests signiﬁcant differences between the different
epibranchial placodes with respect to the effects deregulated RTK
signalling have on their development.
Materials and methods
Mouse lines and embryos
The mouse lines used in this study were maintained on a mixed
genetic background and have been described previously: β actin Cre
(Lewandoski et al., 1997), Ap2αcre (Macatee et al., 2003), Sox17i-2A-
iCre (Sox17icre) (Engert et al., 2009),Wnt1cre (Danielian et al., 1998),
R26R (Soriano, 1999), Spry1tm1.1Jdli (Basson et al., 2005) and
Spry2tm1.1Mrt (Shim et al., 2005). Mice carrying β-actin-cre were
crossed with those carrying conditional Spry1ﬂox and Spry2ﬂox alleles
to generate Spry1−and Spry2−null alleles. Embryos lacking both
genes (Spry1−/−;Spry2−/−) were produced by crossing βactinCre/
βactinCre;Spry1+/−;Spry2+/− males with Spry1ﬂox/ﬂox;Spry2ﬂox/ﬂox fe-
males. For rescue experiments, βactinCre2;Spry1+/−;Spry2+/−;Fgf8+/−
males were crossed with Spry1ﬂox/ﬂox;Spry2ﬂox/ﬂox females using the
Fgf8tm1.2Mrt allele (Meyers et al., 1998). Tissue-speciﬁc mutants were
produced by crossing Cre;Spry1ﬂox/+;Spry2ﬂox/+ males to Spry1ﬂox/ﬂox;
Spry2ﬂox/ﬂox females. Tissue speciﬁc cre recombinase activity was
conﬁrmed using the R26R (Soriano, 1999) or RosaYFP (Srinivas et al.,
2001) reporter mouse lines and in situ hybridisation for Spry1 or Spry2
(Suppl. Fig. 1).
After timedmatings, noon on the day of the vaginal plug was taken
as E0.5. However, due to the rapid growth of the cranial nerves during
development, embryos were staged more accurately using the
number of somites. Harvested embryos were ﬁxed overnight in 4%
formaldehyde at 4 °C, dehydrated and stored in 100% MeOH at
−20 °C until whole mount or section anaylsis. For section analysis,
embryos were embedded in parafﬁn and sectioned at 7 μm in
preparation for immunohistochemistry.
Genotyping
PCR ampliﬁcation using DNA from embryonic yolk sac was used to
genotype harvested embryos. With the exception of Sox17icre, all
other cre lines were genotyped using the following PCR primers, CCT
GGA AAA TGC TTC TGT CCG and CAG GGT GTT ATA AGC AAT CCC,
which give a 390 bp product in cre positive embryos and no product in
wild type embryos. Sox17icre genotyping was performed using
primers GTG TAT AAG CCC GAG ATG G, CTC AAC TGT TCA AGT GGC
AG and GAT CTA TGG TGC CAA GGA TGA C, to give a 446 bp cre
product and a 288 bp wildtype product. Spry1 genotyping primers are
GGG AAA ACC GTG TTC TAA GGA GTA GC, GTT CTT TGT GGC AGA CAC
TCT TCA TTC and CTC AAT AGG AGT GGA CTG TGA AAC TGC; PCR
produces a 342 bp product with a ﬂox allele, a 150 bp product with a
null allele and a 311 bp product with a wild type allele. Genotyping
primers for Spry2 are GGA TGG CTC TGA TCT GAT CC, TTG AGA ACA
TGC CTC GAC C and GCA TGG GCT ATT CAC AAA C, and resulting PCR
products include a 500 bp product with a ﬂox allele, a 225 bp product
with a null allele and a 350 bp product with a wild type allele. Fgf8
genotyping primers are CTA CCC ATC TTC CCC ACA AAA C and CCT GAAAAC TGA ACG CTG GTC C, where a PCR product of 1100 bp is obtained
with a null allele and no product from a wild type allele.Whole mount and section in situ hybridisation
Whole mount RNA in situ hybridisation was performed according
to standard protocols using Digoxigenin-labelled RNA probes. Spry1,
Spry2 (Minowada et al., 1999), Sox10 (Calmont et al., 2009), Crabp1
(Randall et al., 2009), Ngn1 (Ma et al., 1996), Ngn2 (Fode et al., 1998),
and Dlx2 (Depew et al., 2005) antisense RNA probes were produced
from constructs as described in the original publications.Whole mount and section immunohistochemistry
Whole mount and section immunohistochemistry was performed
using anti-neuroﬁlament, RMO-270 (Zymed) at a dilution of 1/3000,
with Alexa 488 goat anti mouse secondary antibody (Invitrogen) at a
dilution of 1/200. Phox2b labelling of motor and sensory neurons was
performed using rabbit anti-Phox2b (Pattyn et al., 1997) at a dilution
of 1/800, with Alexa 546 goat anti rabbit secondary antibody
(Invitrogen) at a dilution of 1/200 and counterstained with DAPI.
Fluorescent pictures were rendered black and white using the
gradient map tool in Adobe Photoshop to optimise visualisation in
print.
In whole mount embryos individual epibranchial cranial nerves on
each side of the embryo were considered separately when analysing
phenotypic incidence (1 embryo=2n) and signiﬁcant difference
probability values were calculated using two-tailed Fisher's exact test
(Prism 5, Graphpad software Inc.).Pharyngeal arch measurements
2D lateral pharyngeal arch areawasmeasured using pictures taken
on a Nikon SMZ1500microscope at a resolution of 2560×1920 pixels.
Measurements were normalised to the total embryo length to account
for variations in embryonic size as indicated in Suppl. Fig. 2. Adobe
Photoshop (Adobe Systems Incorporated) was used to measure 2D
pharyngeal arch area in pixels. Statistical analysis included the
D'Agostino and Pearson omnibus normality test, the unpaired two-
tailed t-test and the two-tailed Mann–Whitney test (Prism 5,
Graphpad software Inc).Results
Sprouty gene expression in relation to epibranchial placode development
To determine whether Sprouty genes may have a function in the
development of the epibranchial ganglia in the mouse, we analysed
the expression of Spry1 and Spry2 between embryonic day (E)8.5 and
E9.5 of development. At E8.5, Spry1 and Spry2 are both expressed in
the pharyngeal ectoderm, endoderm and mesoderm (Figs. 1A–B′).
This pattern of expression is consistent with the expression of several
Fgf genes in these tissues at this time of development and the role of
FGF signalling in the induction of otic fate (Ladher et al., 2010).
Over the next day of development, Spry1 and Spry2 expression
gradually becomes restricted to discrete regions in the pharyngeal
arches. At E9, Spry1 and Spry2 are expressed in the regions where
the Ngn2-positive geniculate and petrosal placodes are induced
(Figs. 1C–E). At E9.5, Sprouty expression was observed ventral to
the geniculate and broadly in a region that appears to overlapwith the
petrosal and nodose placodes (Figs. 1F–H). These data suggest that
Sprouty genes may regulate RTK signalling during epibranchial
placode speciﬁcation and neurogenesis.
Fig. 1. Dynamic Spry1 and Spry2 expression in the developing pharyngeal region.
Sprouty gene expression analysed by RNA in situ hybridisation. Spry1 and Spry2
expression in whole mount E8.5 (8–9ss) (A,B), E9 (16–20ss) (C,D) and E9.5 (25–26ss)
(F,G) embryos, anterior to the top and ventral to the right. Embryos in A and B were
sectioned as indicated by the red line and sections are shown in A′ and B′, respectively.
Note Spry1 and Spry2 expression in the ectoderm (ecto), mesoderm (meso) and
endoderm (endo) at E8.5. Ngn2 expression is shown to indicate the position of the
epibranchial placodes at E9 (E) and E9.5 (H) for comparison. The ﬁrst (PA1), second
(PA2) and third (PA3) pharyngeal arches; otic vesicle (OV); geniculate (G), petrosal (P)
and nodose (N) placodes are labelled.
149S. Simrick et al. / Developmental Biology 358 (2011) 147–155Branchial nerve defects in Sprouty mutants
Whole E10.5 embryos were stained with an antibody to neuroﬁla-
ment to reveal the developing cranial nerves (Figs. 2A–E′). Cranial
nerves in Spry1−/− (n=9/10) and Spry2−/− (n=8/8) embryos
exhibited normal morphologies when compared to wildtype controls
(n=10) at E10.5 (compare Figs. 2B and C with A, Table 1). Most
Spry+/−;Spry2+/− embryos (n=28/34) also exhibited no cranial
nerve defects, conﬁrming that the loss of two Sprouty alleles is
insufﬁcient to cause signiﬁcant cranial nerve defects (Fig. 2D). These
observations suggest that Spry1 and Spry2 may functionally compen-
sate for the loss of each other during branchial nerve development.
In agreement with this hypothesis, Spry1−/−;Spry2−/− embryos
(n=36) displayed severe abnormalities in all the branchial nerves
at E10.5 (Fig. 2E,E′, Table 1). An abnormally developing facial nerve
(VII) was the most prevalent defect observed in Spry1−/−;Spry2−/−
embryos (n=35/36). In control embryos, the VIIth nerve penetrated
the proximal second arch and turned anteriorly once it reached the
distal arch (Fig. 2A and Suppl. Fig. 3). Nerve projections from the facial
ganglion into the second arch appeared stunted and failed to turn in
an anterior direction (red arrow in Fig. 2E,E′, n=34/36, two-tailed
Fisher's exact text, pb0.0001). In some cases, the VIIth nerve also
exhibited severe defasciculation (Fig. 2E′, Suppl. Fig. 3).
To assess the size of the geniculate ganglion, we stained sections
from E10.5 embryos (indicated by white lines in Figs. 2F,J) with
antibodies to Phox2b and neuroﬁlament (Figs. 2G–I, K–M). Phox2b isexpressed in the facial motor neurons (VIIm) in the hindbrain and
epibranchial sensory neurons in the geniculate ganglion (VIIg) (Pattyn
et al., 1997). A normal distribution of Phox2b+motoneurons was
present in rhombomeres 4 and 5 (r4/r5) of Spry1−/−;Spry2−/−
embryos compared to Spry1+/−;Spry2+/− controls (Figs. 2G,H,K,L). By
contrast, the geniculate ganglion was enlarged in Spry1−/−;Spry2−/−
embryos (Figs. 2G,H,K,L; n=34/36, two-tailed Fisher's exact text,
pb0.0001). These observations suggest that the defects in the developing
geniculate ganglion are not secondary to defects in hindbrain
development.
The Spry1−/−;Spry2−/− embryos also exhibited absent or dimin-
ished glossopharyngeal nerve ﬁbres in 13/36 embryos (red asterisk,
Fig. 2E′, two-tailed Fisher's exact text p=0.0029). In the most severe
cases, observed in 5/36 embryos, the early glossopharyngeal nerve
appeared completely missing or fused with the vagus nerve. The
vagus nerve (X) was also abnormal (9/36) or absent (11/36) in
Spry1−/−;Spry2−/− embryos (Fig. 2E, green arrow indicates abnormal
region, n=20/36, two-tailed Fisher's exact text pb0.0001). In
embryos where the vagus nerve could be distinguished, a closer
examination of its projections suggested that projections towards the
heart were diminished and that projections towards the gut were
absent (Suppl. Fig. 3). Consistent with the observation that the vagus
nerve appeared absent in many Spry1−/−;Spry2−/− embryos at E10.5,
no apparent vagus nerve projection into the heart was observed in a
Spry1−/−;Spry2−/− embryo examined at E11.5 (Suppl. Fig. 3).
In summary, defects could be detected in all branchial nerves of
Spry1−/−;Spry2−/− embryos, with defects in the glossopharyngeal
and vagus nerves being less frequent.
Defects in sensory placode formation in the absence of Sprouty genes
One of the ﬁrst markers for epibranchial placode speciﬁcation is
the proneural gene, Ngn2 (Fode et al., 1998; Sommer et al., 1996). To
assess whether the speciﬁcation of individual epibranchial placodes
was compromised in the Sprouty mutants, whole mount in situ
hybridisation using a Ngn2 riboprobe was performed at E9.5 (Fig. 3A).
Ngn2 expression was expanded at the anterodorsal margin of the
second arch, indicating an enlargement of the geniculate placode in
the Spry1−/−;Spry2−/− embryos (Fig. 3B; n=4). This is in line with
the observation of a larger facial ganglion in Spry1−/−;Spry2−/−
embryos at E10.5 (Fig. 2). By contrast, the petrosal and nodose
placodes appeared smaller or missing in the Spry1−/−;Spry2−/−
mutants at E9.5 (Fig. 3B; n=4). These observations suggest that
increased RTK signalling has opposite effects on the geniculate versus
petrosal and nodose placodes at the time of their formation.
After the speciﬁcation of the epibranchial placodes and initiation
of Ngn2 expression, neuronal precursors delaminate from the
placodes and start expressing NeuroD as they migrate towards the
developing ganglia (Fode et al., 1998). Despite the enlarged geniculate
placode, the expression of NeuroD was reduced in the geniculate
ganglion of Spry1−/−;Spry2−/− embryos compared to the Spry+/−;
Spry2+/− controls (red asterisk, Fig. 3D; n=4). This defect appears to
be temporary, as NeuroD expression appears slightly increased
or expanded by E10.5 (red arrows, Fig. 3F; n=4). A more pronounced
effect was observed in the developing glossopharyngeal (IX) and
vagus (X) ganglia, where NeuroD expression appeared missing at E9.5
(green asterisks, Fig. 3D) (n=4), but were present at increased levels
by E10.5 (green arrows, Fig. 3E; n=4).
Taken together, these data indicate that initial placode formation is
affected by the absence of Spry1 and Spry2, with the geniculate
placode increased in size and the petrosal and nodose reduced.
Neuronal differentiation as measured by NeuroD expression is
reduced in all epibranchial ganglia at E9.5, but this effect appears to
be transient with NeuroD expression increased by E10.5. These
observations suggest a transient delay in neuronal differentiation in
Sprouty mutant embryos.
Fig. 2. Cranial nerve abnormalities in Sprouty mutants. Anti-neuroﬁlament immunohistochemistry revealing developing cranial nerves of wildtype (A), Spry1−/− (B), Spry2−/− (C),
Spry1+/−;Spry2+/− (D) and Spry1−/−;Spry2−/− (E,E′) E10.5 embryos is shown. All embryos were between 34 and 36 somite stage. Standard labelling of the cranial nerves was used,
trigeminal ganglion (V) with opthalmic (Vo), maxillary (Vmx) and mandibulary (Vm) branches, facial nerve (VII); vestibulocochlear nerve (VIII); glossopharyngeal nerve (IX) and
the vagus nerve (X). Arrows highlight abnormal morphology and asterisks indicate missing portions. Themajority of developing cranial nerves present in Spry1−/− (B), Spry2−/− (C)
and Spry1+/−;Spry2+/− (D) embryos were comparable to wildtype and the latter genotype was used as a control in this study. Spry1−/−;Spry2−/− embryos have trigeminal defects
(e.g. absent ophthalmic branch of the trigeminal nerve in E), facial nerve defects and glossopharyngeal and vagus cranial nerves display incomplete or irregular bridging between
proximal and distal ganglia (E,E′). (F–M) Neuroﬁlament (RMO-270) and Phox2b immunohistochemistry counter stained with DAPI on sections from E10.5 Spry1+/−;Spry2+/−
control (F–I) and Spry1−/−;Spry2−/− (J–M) mutant embryos. Neuroﬁlament staining is indicated with green ﬂuorescence, Phox2b labelling of motor and sensory neuron nuclei in
red and DAPI stained nuclei in blue. Labelling of markers and genotypes of merged images are as indicated. Other labels include, facial cranial nerve (VII) with motor nuclei in
rhombomere 4 of the hindbrain (VIIm) and sensory neuron nuclei in the developing geniculate ganglion (VIIg). The white lines in F and J indicate plane of section for the images on
the right. Motor nuclei are present in rhombomere 4 of the hindbrain in both the Spry1−/−;Spry2−/−mutant and Spry1+/−;Spry2+/− control embryos and are positioned adjacent to
the developing geniculate ganglion (n=4). The geniculate ganglion is enlarged in the Spry1−/−;Spry2−/− embryos compared to the Spry1+/−;Spry2+/− controls (compare white
arrows in G with K).
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During the course of our investigation, we noticed that the
increase in the geniculate placode appeared to correlate with an
enlargement of the second pharyngeal arch itself. Sizes of the ﬁrst and
second pharyngeal arches were measured in E9.5 embryos using
lateral 2D surface area, and total embryo length was used to
standardise measurements (Table 2). Statistical analysis was per-
formed using Prism 5 (Graphpad software Inc.) and signiﬁcant
differences were calculated using parametric and non-parametric
tests depending on whether the measurement sets passed the
D'Agostino and Pearson test for normality. No signiﬁcant difference
was found between the ﬁrst pharyngeal arch of Spry1−/−;Spry2−/−
(n=36) embryos and Spry+/−;Spry2+/− (n=36) controls (unpaired
two-tailed t-test, p=0.1929). However, a signiﬁcant difference was
found between the second pharyngeal arch sizes of the mutant and
control embryos (n=36 for both genotypes) (unpaired two-tailed t-
test, pb0.0001). This data conﬁrms that the second pharyngeal arch
was signiﬁcantly larger in Spry1−/−;Spry2−/− embryos, whilst the
ﬁrst arch was of normal size. These observations suggest that theenlargement of the geniculate may be secondary to a more general
pharyngeal defect that results in abnormal growth of the second
pharyngeal arch.
Altered neural crest fate in Sprouty-deﬁcient embryos
It has been shown that neural crest cells are not required for the
formation of the epibranchial placodes, but that they play an
important role in directing the migration of epibranchial placodal
cells inwards to the site of ganglion formation (Begbie and Graham,
2001; Coppola et al., 2010). Furthermore, recent experiments in chick
embryos have shown that the inhibition of FGF signalling is also
associated with the failure of neural crest cells to turn on markers of
ectomesenchymal fate when entering the pharyngeal arches; instead,
these cells retained markers of nonectomesenchymal neural crest
(Sox10, Foxd3) which includes cells that contribute to the sensory
ganglia (Blentic et al., 2008). We wished therefore to determine if
deletion of Sprouty genes had consequences for the development of
the neural crest cells and more speciﬁcally whether neural crest cell
fate was altered upon the loss of Sprouty genes. We hypothesised that
Table 1
Branchial nerve phenotypes in E10.5 embryos with indicated genotypes.
VII IX X Total
Wildtype 0 0 0 10
Spry1+/−;Spry2+/− 6 2 2 34
Spry1−/− 0 0 1 10
Spry2−/− 0 0 0 8
Spry1−/−;Spry2−/− 35⁎⁎ 19⁎⁎ 20⁎⁎ 36
Fgf8+/− 0 0 0 8
Spry1−/−;Spry2−/−;Fgf8+/− 4 0 4 4
Ap2αcre;Spry1f/+;Spry2f/+ 2 1 0 14
Ap2αcre;Spry1f/−;Spry2f/− 6⁎⁎ 1 0 8
Wnt1cre;Spry1f/+;Spry2f/+ 0 0 0 8
Wnt1cre;Spry1f/−;Spry2f/− 0 0 0 8
Sox17icre;Spry1f/+;Spry2f/+ 0 0 0 12
Sox17icre;Spry1f/f;Spry2f/f 3⁎ 0 0 6
The number of defective nerves is recorded for each genotype, along with the total
number of nerves analysed. Statistical analysis was performed using Prism 5 (Graphpad
software Inc). Two-tailed Fisher's exact test was used to calculate the probability of a
signiﬁcant difference. For statistical analyses, Spry1−/−, Spry2−/− and Spry1+/−;
Spry2+/− embryos were compared with wildtype, Spry1−/−;Spry2−/− with Spry1+/−;
Spry2+/− and Xcre;Spry1f/f;Spry2f/f or Xcre;Spry1f/−;Spry2f/−with Xcre;Spry1f/+;Spry2f/+
embryos.
⁎ pb0.05.
⁎⁎ pb0.01.
Table 2
2D lateral pharyngeal arch area standardised for the height of the embryo at E9.5.
Genotype Number First pharyngeal
arch (StD)
Second pharyngeal
arch (StD)
Spry1+/−;Spry2+/− 36 11114 (1198) 7056 (894.1)
Spry1−/−;Spry2−/− 36 11532 (1486) 9040** (1266)
Ap2αcre;Spry1f/+;Spry2f/+ 4 11275 (1110) 6420 (668.5)
Ap2αcre;Spry1f/−;Spry2f/− 4 9652 (1556) 6441 (333.4)
Wnt1cre;Spry1f/+;Spry2f/+ 8 10922 (796.7) 7091 (682.6)
Wnt1cre;Spry1f/−;Spry2f/− 8 11284 (775.8) 7410 (637.4)
Sox17cre;Spry1f/+;Spry2f/+ 16 10652 (847.9) 6836 (772.1)
Sox17cre;Spry1f/−;Spry2f/− 12 10912 (1200) 7628* (1036)
The 2D lateral pharyngeal arch area was measured using Adobe Photoshop (Adobe
Systems Incorporated) and standardised to the length of the embryo (Suppl. Fig. 2).
Statistical signiﬁcant differences were calculated using Prism 5 (Graphpad software
Inc). With the exception of a single (underlined) group, all passed the D'Agostino
and Pearson omnibus normality test and were analysed using the unpaired two-tailed
t-test, *pb0.05 and **pb0.01. Two-tailed Mann–Whitney test was used for the
measurement set that failed the normality test. Spry1−/−;Spry2−/− embryos were
compared with Spry1+/−;Spry2+/− and Xcre;Spry1f/f;Spry2f/f or Xcre;Spry1f/−;Spry2f/−
with Xcre;Spry1f/+;Spry2f/+embryos for the purpose of statistical analysis.
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ectomesenchymal fate markers at the expense of non-ectomesenchymal
markers.We therefore used a number of neural crestmarkers to visualise
these cells in the developing embryo.
Whole-mount in situ hybridisation for a pan-neural crest marker
Crabp1 showed that all the neural crest streams were present and
migrating to the appropriate regions in the Spry1−/−;Spry2−/−
mutants (Figs. 4A,B; n=8). To distinguish between ectomesenchymal
and non-ectomesechymal neural crest cells we usedDlx2 and Sox10 as
respective markers (Baker et al., 1997; Blentic et al., 2008). The
intensity of Sox10 expression where the hyoid neural crest stream
approaches the geniculate placode was slightly reduced in Spry1−/−;
Spry2−/− mutants (red arrow, Figs. 4C,D; n=8). Intriguingly, Dlx2
expression appeared to respond in the opposite manner and was
markedly upregulated in this region (red arrows, Figs. 4E,F; n=4).
These gene expression changes are consistent with a change in neural
crest cell fate from non-ectomesenchymal to ectomesenchymal in the
vicinity of the geniculate placode. Sox10 expression was also
decreased in the post otic stream where the petrosal and nodose
placodes develop (green asterisks, Figs. 4C,D; n=8), although no
corresponding up-regulation of Dlx2 expression in the third and
developing fourth pharyngeal arches was observed (Figs. 4E,F; n=4).
To conﬁrm that this apparent switch in neural crest cell fate is
associated with increased RTK signalling, we determined the ex-
pression of Erm (Etv5), a downstream target of FGF signalling (KleinFig. 3. Defects in epibranchial placode formation and neuronal differentiation in Sprouty mu
the developing placodes and a NeuroD RNA probe (C–F) to identify differentiating neurobla
gene expression had been lost. Annotations are the same as in Figs. 1 and 2; with the vest
Spry1−/−;Spry2−/− E9.5 embryos compared to Spry1+/−;Spry2+/− controls (A,B) (n=6). C
Spry2−/− embryos. NeuroD expression is reduced at E9.5 (C,D) (n=4). NeuroD expression
(green arrows) ganglia of Spry1−/−;Spry2−/− embryos compared to Spry1+/−;Spry2+/− conet al., 2008). Erm was upregulated in the Spry1−/−;Spry2−/−mutants
compared to controls, including in regions where the altered Sox10
and Dlx2 expression was detected (Figs. 4G,H; n=8). These ﬁndings
are consistent with previous experiments in the chick embryo
showing that increased FGF signalling promoted ectomesenchymal
fate at the expense of neurogenic fate (Blentic et al., 2008).
Epithelial Sprouty gene expression regulates neural crest contribution to
the forming facial ganglia
We next asked whether the defects in neural crest and placodal
developmentwere cell autonomous in Spry1−/−;Spry2−/−mutants. Spry1
and Spry2 were excised in different tissues using several cre lines. No
defects were detected in E10.5 Wnt1cre;Spry1f/−;Spry2f/−embryos
(n=8), indicating that the loss of Sprouty genes in the neural crest is
not sufﬁcient to cause cranial nerve defects (Figs. 5A,B, Table 1).
Furthermore Ngn2 expression was normal in the epibranchial placodes
of these mutants (Figs. 5E,F; n=4), indicating that defects in the
development of the epibranchial placodes were not caused by defects in
the neural crest alone.
To determine whether the loss of Spry1 and Spry2 in the
pharyngeal ectoderm is sufﬁcient to cause defects in placodal
neurogenesis, we deleted Sprouty genes from the pharyngeal
ectoderm and neural crest using an Ap2αcre line (Macatee et al.,
2003). As no defects were present in the neural crest-speciﬁc
conditional knockouts, defects in the ectoderm+neural crest-speciﬁc
gene deletion experiments can be ascribed to functions in the
ectoderm. The developing facial nerve in Ap2αcre;Spry1f/–;Spry2f/–
mutants showed a similar phenotype to Spry1−/−;Spry2−/− embryos,tant embryos. Whole mount in situ hybridisation with a Ngn2 RNA probe (A,B) to detect
sts. Arrows indicate changes in gene expression and asterisks highlight regions where
ibulo-acoustic nerve (VIII) also indicated. Note the enlarged geniculate placode in the
onversely, note the smaller or absent petrosal and nodose placodes in the Spry1−/−;
recovers and appears increased in the geniculate (red arrow), geniculate and petrosal
trols (n=4) at E10.5 (E,F).
Fig. 4. Neural crest cell fate appears altered in Spry1−/−;Spry2−/− embryos.
Wholemount in situ hybridisation of control (A,C,E,G) and Spry1−/−;Spry2−/− embryos
(B,D,F,H) with neural crest markers Crabp1 (A,B) (n=6), Sox10 (C,D) (n=4), Dlx2 (E,F)
(n=4), and a reporter of FGF signalling Erm (G,H) all at E9 (20–22 somite stage).
Neural crest streams, pharyngeal arches and otic vesicle are labelled as in Figs. 1 and 2.
Arrows illustrate changes in gene expression and asterisks indicate regions with absent
gene expression.
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Fisher's exact test p=0.0083) with abnormal nerve projections into
the second arch (n=3/8, two tailed Fisher's exact test p=0.0364)
(Table 1 and Fig. 5C). Curiously, most glossopharyngeal and all vagus
nerves appeared normal in these mutants. Ngn2 expression as a
marker of epibranchial placodes at E9.5, conﬁrmed that the geniculate
placode was enlarged in these mutants (Figs. 5G,H). A slightly smaller
petrosal placode was seen in Ap2αcre;Spry1f/–;Spry2f/– embryos
(n=2; Figs. 5G,H). These data suggest a cell autonomous role for
Spry1 and Spry2 in the ectoderm during the development of the
geniculate and to a lesser extent, the petrosal placode. To determine
whether the enlarged geniculate placode was also associated with a
larger second arch in Ap2αcre;Spry1f/–;Spry2f/– mutant embryos, the
2D lateral area of the second arch was measured. The second
pharyngeal arch was not larger in these conditional mutants (n=8,
unpaired two tailed t-test p=0.9579, Table 2), indicating that theenlarged geniculate is not due to a general enlargement of the 2nd
arch. This observation indicates a cell autonomous role for Sprouty
genes in the pharyngeal ectoderm during facial nerve development.
As signals from the pharyngeal endoderm have been implicated in
placodal neurogenesis (Begbie et al., 1999; Nechiporuk et al., 2005),
we also deleted Spry1 and Spry2 from this tissue using the Sox17icre
line (Engert et al., 2009). Half of the facial nerves examined were
defective in Sox17icre;Spry1f/f;Spry2f/f embryos (n=3/6, two tailed
Fisher's exact test p=0.0245). By contrast, the other branchial nerves
appeared to develop normally in these conditional mutants (Fig. 5D).
The geniculate placode was slightly larger and the petrosal slightly
smaller in Sox17icre;Spry1f/f;Spry2f/fmutant embryos (n=4, Figs. 5I,J).
These observations indicate that the loss of Sprouty gene function in
the endoderm can affect the early development of the epibranchial
placodes, albeit not as severely as when these genes are lost in all
tissues. The 2D lateral area of the second arch in the Sox17icre;Spry1f/f;
Spry2f/f mutants (n=12) was slightly increased compared to controls
(n=16) (unpaired two tailed t-test, p=0.0352, Table 2), suggesting
that the enlarged geniculate in these mutants might be secondary to
arch defects.
Taken together, these observations suggest that defects in the
pharyngeal endoderm caused by the deletion of Sprouty genes in the
endoderm can have non cell-autonomous effects on the ectodermal
placodes. Relatively small changes in Ngn2 expression in the
epibranchial placodes appear to be sufﬁcient to cause some defects
in the facial nerve, but insufﬁcient to cause defects in nodose and
vagus nerves.
Fgf8 haploinsufﬁciency partially rescues the Spry1;Spry2 double
knockout phenotype
Sprouty proteins regulate signalling via the MAPK pathway, which
is activated downstream of a number of receptor tyrosine kinases,
including FGF receptors and RET (Basson et al., 2005, 2006; Mason
et al., 2006; Rozen et al., 2009; Shim et al., 2005). To determine to
what extent the observed defects are due to hyperactive FGF
signalling, we attempted to rescue the Spry1−/−;Spry2−/− mutant
phenotype by reducing the Fgf8 gene dosage as previously described
for Spry2 mutant phenotypes (Shim et al., 2005). The epibranchial
cranial nerves in Spry1−/−;Spry2−/−;Fgf8+/− embryos (Figs. 6C,D)
exhibited similar phenotypes to those observed in Spry1−/−;Spry2−/−
(Fig. 6B). However, whereas the incidence of phenotypes found in the
developing facial and vagus cranial nerves were similar between
Spry1−/−;Spry2−/− and Spry1−/−;Spry2−/−;Fgf8+/− embryos, the
density of glossopharyngeal nerve ﬁbres was rescued in some
Spry1−/−;Spry2−/−;Fgf8+/− embryos (Figs. 6C,D, Table 1). To explore
the reason for this partial phenotypic rescue further, we compared the
forming epibranchial placodes in Spry1−/−;Spry2−/− and Spry1−/−;
Spry2−/−;Fgf8+/− embryos. Both the enlarged geniculate and absent
petrosal and nodose phenotypes were partially rescued by a reduction
in the Fgf8 gene dosage at E9.5 (n=4; Figs. 6E–G). This observation
suggests that increased signalling downstream of FGF8 may be
responsible for these early defects in placodal development.
Discussion
In this manuscript we describe the analysis of branchial nerve
phenotypes in embryos in which two Sprouty genes (Spry1 and Spry2)
were deleted. Our analysis indicates that the facial nerve is most
sensitive to the loss of Sprouty genes with 97% of all facial nerves
investigated being abnormal, compared to the glossopharyngeal
(53%) and vagus (56%) nerves. We further show that the facial
nerve phenotype could be observed upon the deletion of these genes
from either the pharyngeal endoderm or ectoderm, whereas the other
two nerves developed normally in these conditional mutants. Thus,
our observations suggest that abnormal glossopharyngeal and vagus
Fig. 5. Sprouty function in the pharyngeal epithelia is required for normal facial nerve morphogenesis. (A–D) Anti-neuroﬁlament (RMO-270) whole mount immunohistochemistry
revealing cranial nerve morphology in Spry1 and Spry2 tissue speciﬁc conditional knockout E10.5 embryos. Tissue speciﬁc gene deletion was achieved using the cre-lox system with
Spry1 and Spry2 ﬂox alleles and Wnt1cre (B, neural crest), Ap2αcre (C, ectoderm and neural crest), and Sox17icre (D, endoderm). A stage-matched Spry1f/+;Spry2f/+ litter-mate
control is displayed to indicate normal cranial nerve morphology (A). Genotypes are as indicated and labels are as before. Red arrows illustrate changes in cranial nerve morphology.
(E–J) Wholemount in situ hybridisationwith Ngn2 antisense RNA probe to reveal the epibranchial placodes inWnt1cre-, AP2acre-, or Sox17icre-mediated conditional knockout (cko)
embryos as indicated. Note the enlarged geniculate placode and slightly smaller petrosal in the Ap2αcre;Spry1f/−;Spry2f/−and Sox17cre;Spry1f/f;Spry2f/f embryos (red arrows in H
and J). The epibranchial placodes, geniculate (G), petrosal (P) and nodose (N) are labelled.
153S. Simrick et al. / Developmental Biology 358 (2011) 147–155nerve development may require the deletion of Sprouty genes from
several tissues at once. Finally, we present evidence that early
epibranchial placode development is perturbed in Sprouty-deﬁcientFig. 6. Spry1−/−;Spry2−/− epibranchial cranial nerve phenotype is partially rescued by
developing cranial nerves in Spry1+/−;Spry2+/−, Spry1−/−;Spry2−/− and Spry1−/−;Spry2−
Spry2−/−;Fgf8+/− embryos (red arrows in C and D) compared to the Spry1−/−;Spry2−/− em
RNA probe. Note the enlarged geniculate (red arrow) and absence of petrosal and nodos
phenotypes in the Spry1−/−;Spry2−/−;Fgf8+/− embryo, especially the presence of the petroembryos due to hyperactive FGF8 signalling. Intriguingly, reducing the
Fgf8 gene dosage rescues these early phenotypes but is only sufﬁcient
to partially rescue the glossopharyngeal phenotype. This observationFgf8 heterozygosity. (A–D) Anti-neuroﬁlament immunohistochemistry showing the
/−;Fgf8+/− embryos. Note the increased glossopharyngeal nerve ﬁbres in Spry1−/−;
bryo (B). (E–G) Epibranchial placodes in E9.5 embryos as revealed by a Ngn2 antisense
e placodes (red stars) in the Spry1−/−;Spry2−/− embryo (F), and the rescue of these
sal and nodose placodes (red arrows in G).
154 S. Simrick et al. / Developmental Biology 358 (2011) 147–155suggests that Sprouty proteins may also inhibit signalling down-
stream of other factors that regulate branchial nerve development.
Multiple FGF ligands (FGF3, FGF8, FGF10 and FGF15) are expressed in
the developing pharyngeal region and show considerable functional
redundancy during otic development (Schimmang, 2007; Wright and
Mansour, 2003). In addition, signals from other factors such as GDNF
can also be regulated by Sprouty (Basson et al., 2005, 2006).
Our results indicate that the effects of deregulated RTK signalling
on the early development of the geniculate placode differ from effects
on the petrosal and nodose. These observations are consistent with
ﬁndings in zebraﬁsh, where it has been proposed that the mecha-
nisms that induce formation of the facial and large vagal placodes
differ from those that control glossopharyngeal and small vagal
placode formation (Nechiporuk et al., 2005). We found that increased
RTK signalling is associated with an enlarged geniculate placode,
whereas the petrosal and nodose are smaller under these conditions.
Our data are consistent with previous studies in the mouse embryo, in
particular those that analysed the effects of reduced FGF signalling on
pharyngeal development. Trokovic et al. have shown that several FGF
genes, Fgf3, Fgf8 and Fgf15 are expressed in the developing second
pharyngeal arch and that this arch is severely hypoplastic in Fgfr1
hypomorphic mutants (Trokovic et al., 2005). Their data suggest that
the second arch is most dependent upon FGF signalling for its
development. Furthermore, the geniculate placode is also hypoplastic
in these mutants, whereas the petrosal and nodose develop normally.
Our data suggest that increased FGF signalling upon the deletion of
Sprouty genes results in the opposite phenotype i.e. an enlarged
second arch and geniculate placode. Thus, the facial nerve defects in
Sprouty mutants could, at least in part, be explained by the unique
sensitivity of the second arch to perturbations in FGF signalling.
However, the geniculate, placode and facial nerve phenotypes were
still observed in ectoderm/neural crest-speciﬁc conditional knockout
embryos, despite the second arch being of normal size in these
mutants. This observation suggests that these two phenotypes are not
necessarily causally linked, and implies a cell-autonomous role for
Sprouty genes in the pharyngeal ectoderm itself during geniculate
placode speciﬁcation, consistent with a model proposed by Trokovic
et al. (Trokovic et al., 2005). Interestingly, our conditional gene
deletion experiments suggest that the enlarged arch in the Sprouty
mutants, might primarily be due to the loss of Sprouty genes in the
endoderm.
Whereas the development of the posterior epibranchial placodes,
the petrosal and nodose, is not affected when FGF signalling is
reduced as in Fgfr1 or Fgf8 hypomorphs (Chi et al., 2003; Trokovic
et al., 2005), we ﬁnd that increased RTK signalling delays the forma-
tion of these placodes. A recent analysis of early otic speciﬁcation
in Spry1−/−;Spry2−/− embryos revealed that the Pax2+;Pax8+;
Dlx5+;Foxi2− otic placode is expanded in these mutants, apparently
at the expense of the Foxi2+ non-otic ectoderm, which presumably
includes precursors of the epibranchial placodes (Mahoney Rogers
et al., 2011). Thus, the loss of Sprouty genes does not appear to affect
the earlier steps of otic/epibranchial development, but promotes otic
fate at the expense of non-otic ectoderm fate at later stages of
development. Our genetic rescue experiments suggest that the defects
in these two caudal epibranchial placodes are, at least in part, due to
deregulated signalling downstream of Fgf8. As Fgf8, Fgf3 and Fgf10 are
functionally redundant during speciﬁcation of the pre-otic ﬁeld and
otic placode (Alvarez et al., 2003; Dominguez-Frutos et al., 2009;
Ladher et al., 2005;Wright andMansour, 2003; Zelarayan et al., 2007),
one would predict that compound mutants in these genes would also
exhibit defects in the branchial nerves. However, as these FGFs are
required at an early stage of development for the speciﬁcation of the
otic-epibranchial progenitor domain, these mutants are likely to
exhibit reduced speciﬁcation of epibranchial placodes in addition to
the already-described reduction in the size of the otic placode. Further
work will be required to test this hypothesis.Our analysis of neurogenesis in Sprouty-deﬁcient embryos suggests
that the differentiation of Ngn2-positive placodal cells into NeuroD-
positive neuroblasts was inhibited by excessive RTK signalling. The
reduction inNeuroD expressionwas consistent in all developing branchial
ganglia. This defect was transient suggesting that neural differentiation
was merely delayed for a short time. A transient delay, as opposed to a
complete block in neural differentiation is consistentwith theﬁnding that
the facial ganglionwas bigger in Sproutymutants, as the larger number of
Ngn2+ placodal precursors speciﬁed in these mutants, is expected to
eventually contribute more neurons to this ganglion. FGF signals have
been reported to inhibit neuronal differentiation in other developmental
contexts, including the prospective chick spinal cord (Diez del Corral et al.,
2002, 2003). Studies in the chick embryo have identiﬁed one potential
regulator of epibranchial neurogenesis as BMP7 (Begbie et al., 1999). The
expression of Bmp7 was not signiﬁcantly altered in Fgfr1 hypomorphs
(Trokovic et al., 2005), or Spry1−/−;Spry2−/− mutants (this study, not
shown), indicating that FGF signalling is unlikely to affect neurogenesis by
controlling Bmp7 gene expression. However, activated ERK/MAPK has
been shown to inhibit BMP signalling at the level of Smad proteins in
developmental contexts (Pera et al., 2003). Thus, increased RTK signalling
in Sprouty mutants may inhibit the neurogenic activity of BMP7 through
inhibiting Smad activity.
Chick and zebraﬁsh experiments have shown that epithelial FGF
signalling regulates neural crest cell fate decisions in the pharyngeal
apparatus, promoting a ectomesenchymal fate over a neurogenic fate
(Blentic et al., 2008). Our results suggest that this also applies to the
mouse embryo. The neurogenic crest marker Sox10 is downregulated
and the ectomesenchymal neural crest marker, Dlx2, upregulated in
regions of increased RTK signalling in Sprouty mutants.
In conclusion, previous studies have identiﬁed a number of
different functions for FGF signalling in the pharyngeal region. Data
presented in this manuscript demonstrate that the RTK antagonists,
Sprouty1 and Sprouty2 are essential for the normal development of
the branchial nerves. The loss of Spry1 and Spry2 results in a number
of defects, including an enlargement of the second pharyngeal arch,
defects in epibranchial placode formation and alterations in neural
crest fate. Our attempts to dissect the tissue-speciﬁc requirements of
Sprouty gene function in these processes showed that the second arch
expansion is at least partially due to the loss of Sprouty genes in the
endoderm. Finally, the expansion of the geniculate placode and facial
nerve dysmorphology are due to the loss of Sprouty genes from the
pharyngeal endoderm and ectoderm. Thus, a rather complicated
picture emerges that suggests that Sprouty gene function is required
in several cell types and that the branchial nerve phenotypes observed
in Sprouty-deﬁcient embryos cannot be explained by Sprouty loss
within a single tissue or cell type.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.07.024.
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